ESSA Pharma Inc.·4

Jan 8, 8:06 PM ET

Virsik Peter 4

4 · ESSA Pharma Inc. · Filed Jan 8, 2024

Insider Transaction Report

Form 4
Period: 2024-01-05
Virsik Peter
Chief Operating Officer
Transactions
  • Sale

    Common Shares

    2024-01-05$6.11/sh699$4,27114,022 total
Footnotes (1)
  • [F1]The amount reflects the sale of shares pursuant to Mr. Virsik's 10b5-1 trading plan. The Rule 10b5-1 trading plan was entered into on August 31, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION